ZAVEDOS Side Effects

6783435-1 | Pneumonitis, Respiratory Failure, Septic Shock
on Jun 10, 2010 Male patient from ITALY , 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis, respiratory failure, septic shock. Zavedos dosage: 22 Mg X Day, (12 Mg/m2). During the same period patient was treated with CYCLOPHOSPHAMIDE (546 Mg X Day, (300 Mg/m2)) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (2 Mg Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6781961-2 | Atrial Fibrillation, Bradycardia, Supraventricular Extrasystoles
Patient was taking Zavedos (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, supraventricular extrasystoles on Jun 10, 2010 from FRANCE Additional patient health information: Male patient , 74 years of age, was diagnosed with acute myeloid leukaemia and. Zavedos dosage: Unk. Patient was hospitalized.

6733541-2 | Stomatitis
Adverse event was reported on May 11, 2010 by a Male patient taking Zavedos (View Usage) (Dosage: 23 Mg, X/day) was diagnosed with acute myeloid leukaemia and. Location: ITALY , 37 years of age, After Zavedos was administered, patient had the following side effects: stomatitis. During the same period patient was treated with ARACYTIN (380 Mg, X/day) (View Aracytin Review and Aracytin Label ), ETOPOSIDE (190 Mg, X/day) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6713826-6 | Pneumonitis, Respiratory Failure, Septic Shock
on Apr 26, 2010 Male patient from ITALY , 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis, respiratory failure, septic shock. Zavedos dosage: 22 Mg X Day. During the same period patient was treated with CYCLOPHOSPHAMIDE (546 Mg X Day) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (2 Mg Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).


6711455-1 | Hepatotoxicity
on Apr 26, 2010 Male patient from ITALY , 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient had the following side effects: hepatotoxicity. Zavedos dosage: 32 Mg. During the same period patient was treated with CYTARABINE (4 G, X/day) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6687251-0 | Chest Discomfort, Haemoglobin Decreased
Patient was taking Zavedos (View Usage). After Zavedos was administered, patient had the following side effects: chest discomfort, haemoglobin decreased on Apr 07, 2010 from NETHERLANDS Additional patient health information: Male patient , 55 years of age, weighting 211.6 lb, . Zavedos dosage: Unk. During the same period patient was treated with ZOPLICONE (7.5 Mg, 2x/day) (View Zoplicone Review and Zoplicone Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ), MOVICOLON (View Movicolon Review and Movicolon Label ), HEPARIN (500 Iu, 1x/day) (View Heparin Review and Heparin Label ), AMBISOME (10 Mg, Unk) (View Ambisome Review and Ambisome Label ), CIPROFLOXACIN (50 Mg, 2x/day) (View Ciprofloxacin Review and Ciprofloxacin Label ), FLUCONAZOLE (400 Mg, 1x/day) (View Fluconazole Review and Fluconazole Label ).

6663496-0 | Diarrhoea, Erythema, Gastrointestinal Inflammation, Stomatitis Necrotising
Adverse event was reported on Mar 22, 2010 by a Female patient taking Zavedos (View Usage) (Dosage: 21 Mg, Daily) was diagnosed with acute myeloid leukaemia and. Location: ITALY , 52 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, erythema, gastrointestinal inflammation, stomatitis necrotising. During the same period patient was treated with ARACYTIN (358 Mg, Daily) (View Aracytin Review and Aracytin Label ), ETOPOSIDE (179 Mg, Daily) (View Etoposide Review and Etoposide Label ), HYDROXYCARBAMIDE (3 G, Daily) (View Hydroxycarbamide Review and Hydroxycarbamide Label ). Patient was hospitalized.

6661538-X | Cellulitis, Hyperpyrexia, Oropharyngeal Pain, Stomatitis
on Mar 24, 2010 Male patient from ITALY , 18 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Zavedos (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), hyperpyrexia, oropharyngeal pain, stomatitis. Zavedos dosage: 48 Mg Total. During the same period patient was treated with URBASON (20 Mg Daily) (View Urbason Review and Urbason Label ), VESANOID (44 Mg Daily) (View Vesanoid Review and Vesanoid Label ). Patient was hospitalized.

6661535-4 | Cellulitis, Pneumonia Fungal
on Mar 23, 2010 Female patient from ITALY , 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). After Zavedos was administered, patient had the following side effects: cellulitis (What is cellulitis?), pneumonia fungal. Zavedos dosage: 16 Mg Daily. During the same period patient was treated with ARACYTIN (318 Mg Daily) (View Aracytin Review and Aracytin Label ). Patient was hospitalized.

6659089-1 | Enterobacter Sepsis, Epididymitis
Patient was taking Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: enterobacter sepsis, epididymitis on Mar 19, 2010 from ITALY Additional patient health information: Male patient , 69 years of age, was diagnosed with acute myeloid leukaemia and. Zavedos dosage: 24 Mg X Day. During the same period patient was treated with ARACYTIN (400 Mg X Day) (View Aracytin Review and Aracytin Label ).

6655632-7 | Aspergillosis, Febrile Bone Marrow Aplasia, Headache, Hypertransaminasaemia
Adverse event was reported on Mar 17, 2010 by a Male patient taking Zavedos (View Usage) (Dosage: 12 Mg/m2, X/day) was diagnosed with lymphocytic leukaemia and. Location: ITALY , 35 years of age, Patient had the following side effects: aspergillosis, febrile bone marrow aplasia, headache (What is headache?), hypertransaminasaemia. During the same period patient was treated with ENDOXAN BAXTER (300 Mg/m2, X/day) (View Endoxan Baxter Review and Endoxan Baxter Label ), VINCRISTINA TEVA (6 Mg, Total Dose) (View Vincristina Teva Review and Vincristina Teva Label ), ELSPAR (12000 Iu, Daily) (View Elspar Review and Elspar Label ).

6648749-4 | Stomatitis
on Mar 12, 2010 Male patient from ITALY , 37 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). After Zavedos was administered, patient had the following side effects: stomatitis. Zavedos dosage: 23 Mg, X/day. During the same period patient was treated with ARACYTIN (380 Mg, X/day) (View Aracytin Review and Aracytin Label ), ETOPOSIDE (190 Mg, X/day) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

6646869-1 | Diarrhoea, Erythema, Gastrointestinal Inflammation, Stomatitis Necrotising
on Mar 11, 2010 Female patient from ITALY , 52 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, erythema, gastrointestinal inflammation, stomatitis necrotising. Zavedos dosage: 21 Mg, Daily. During the same period patient was treated with CYTARABINE (358 Mg, Daily) (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (179 Mg, Daily) (View Etoposide Review and Etoposide Label ), HYDROXYCARBAMIDE (3 G, Daily) (View Hydroxycarbamide Review and Hydroxycarbamide Label ). Patient was hospitalized.

6646837-X | Enterobacter Sepsis, Epididymitis
Patient was taking Zavedos (View Usage). Patient had the following side effects: enterobacter sepsis, epididymitis on Mar 11, 2010 from ITALY Additional patient health information: Male patient , 69 years of age, was diagnosed with acute myeloid leukaemia and. Zavedos dosage: 24 Mg X Day. During the same period patient was treated with CYTARABINE (400 Mg X Day) (View Cytarabine Review and Cytarabine Label ).

6644810-9 | Hyperpyrexia, Pneumonitis, Respiratory Failure, Septic Shock
Adverse event was reported on Mar 11, 2010 by a Male patient taking Zavedos (View Usage) (Dosage: 22 Mg X Day) was diagnosed with acute myeloid leukaemia and. Location: ITALY , 71 years of age, After Zavedos was administered, patient had the following side effects: hyperpyrexia, pneumonitis, respiratory failure, septic shock. During the same period patient was treated with CYCLOPHOSPHAMIDE (546 Mg X Day) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (2 Mg Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6631712-7 | Anaemia, Colitis Ulcerative, Hepatotoxicity, Intestinal Haemorrhage, Mucosal Inflammation, Pulmonary Mycosis
on Feb 28, 2010 Female patient from ITALY , 20 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, colitis ulcerative, hepatotoxicity, intestinal haemorrhage, mucosal inflammation, pulmonary mycosis. Zavedos dosage: 20 Mg, X/day. During the same period patient was treated with CYCLOPHOSPHAMIDE (492 Mg, X/day) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (4 Mg, Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (60 Mg, X/day) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), DEXAMETHASONE PHOSPHATE (16 Mg, X/day) (View Dexamethasone Phosphate Review and Dexamethasone Phosphate Label ), METHOTREXATE (12 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), CYTARABINE (50 Mg) (View Cytarabine Review and Cytarabine Label ), LEUPROLIDE ACETATE (1 Unit) (View Leuprolide Acetate Review and Leuprolide Acetate Label ).

6585220-2 | Diarrhoea, Erythema, Gastrointestinal Inflammation, Stomatitis Necrotising
on Feb 02, 2010 Female patient from ITALY , 52 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient had the following side effects: diarrhoea, erythema, gastrointestinal inflammation, stomatitis necrotising. Zavedos dosage: 21 Mg, Daily. During the same period patient was treated with ARACYTIN (358 Mg, Daily) (View Aracytin Review and Aracytin Label ), ETOPOSIDE (179 Mg, Daily) (View Etoposide Review and Etoposide Label ), HYDROXYCARBAMIDE (3 G, Daily) (View Hydroxycarbamide Review and Hydroxycarbamide Label ). Patient was hospitalized.

6585116-6 | Cellulitis, Hyperpyrexia, Oropharyngeal Pain, Stomatitis
Patient was taking Zavedos (View Usage). After Zavedos was administered, patient had the following side effects: cellulitis (What is cellulitis?), hyperpyrexia, oropharyngeal pain, stomatitis on Feb 05, 2010 from ITALY Additional patient health information: Male patient , 18 years of age, was diagnosed with acute promyelocytic leukaemia and. Zavedos dosage: 48 Mg. During the same period patient was treated with URBASON (20 Mg Daily) (View Urbason Review and Urbason Label ), VESANOID (44 Mg Daily) (View Vesanoid Review and Vesanoid Label ). Patient was hospitalized.

6582793-0 | Hyperpyrexia, Pneumonitis, Respiratory Failure, Septic Shock
Adverse event was reported on Feb 04, 2010 by a Male patient taking Zavedos (View Usage) (Dosage: 22 Mg X Day) was diagnosed with acute myeloid leukaemia and. Location: ITALY , 71 years of age, Patient experienced the following unwanted or unexpected effects: hyperpyrexia, pneumonitis, respiratory failure, septic shock. During the same period patient was treated with CYCLOPHOSPHAMIDE (546 Mg X Day) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (2 Mg Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6582766-8 | Hepatotoxicity
on Feb 03, 2010 Male patient from ITALY , 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient had the following side effects: hepatotoxicity. Zavedos dosage: 32 Mg. During the same period patient was treated with CYTARABINE (4 G, X/day) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6579245-0 | Cellulitis, Pneumonia Fungal
on Feb 04, 2010 Female patient from ITALY , 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). After Zavedos was administered, patient had the following side effects: cellulitis (What is cellulitis?), pneumonia fungal. Zavedos dosage: 16 Mg Daily. During the same period patient was treated with ARACYTIN (318 Mg Daily) (View Aracytin Review and Aracytin Label ). Patient was hospitalized.

6578138-2 | Enterobacter Sepsis, Epididymitis
Patient was taking Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: enterobacter sepsis, epididymitis on Feb 02, 2010 from ITALY Additional patient health information: Male patient , 69 years of age, was diagnosed with acute myeloid leukaemia and. Zavedos dosage: 24 Mg X Day. During the same period patient was treated with ARACYTIN (400 Mg X Day) (View Aracytin Review and Aracytin Label ).

6568171-9 | Colitis Ulcerative, Gastrointestinal Inflammation, Hepatotoxicity, Intestinal Haemorrhage, Pulmonary Mycosis
Adverse event was reported on Jan 25, 2010 by a Female patient taking Zavedos (View Usage) (Dosage: 20 Mg, X/day) was diagnosed with acute lymphocytic leukaemia and. Location: ITALY , 20 years of age, Patient had the following side effects: colitis ulcerative, gastrointestinal inflammation, hepatotoxicity, intestinal haemorrhage, pulmonary mycosis. During the same period patient was treated with CYCLOPHOSPHAMIDE (492 Mg, X/day) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (4 Mg, Total) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (60 Mg, X/day) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), DEXAMETHASONE PHOSPHATE (16 Mg, X/day) (View Dexamethasone Phosphate Review and Dexamethasone Phosphate Label ), METHOTREXATE (12 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), ARACYTIN (50 Mg) (View Aracytin Review and Aracytin Label ), LEUPROLIDE ACETATE (1 Unit) (View Leuprolide Acetate Review and Leuprolide Acetate Label ).

6566760-9 | Aspergillosis, Febrile Bone Marrow Aplasia, Headache, Hypertransaminasaemia
on Jan 21, 2010 Male patient from ITALY , 35 years of age, was diagnosed with lymphocytic leukaemia and was treated with Zavedos (View Usage). After Zavedos was administered, patient had the following side effects: aspergillosis, febrile bone marrow aplasia, headache (What is headache?), hypertransaminasaemia. Zavedos dosage: 12 Mg/m2, X/day. During the same period patient was treated with ENDOXAN BAXTER (300 Mg/m2, X/day) (View Endoxan Baxter Review and Endoxan Baxter Label ), VINCRISTINA TEVA (6 Mg, Total Dose) (View Vincristina Teva Review and Vincristina Teva Label ), ELSPAR (12000 Iu, Daily) (View Elspar Review and Elspar Label ).

6525284-5 | Bronchopulmonary Aspergillosis, Pulmonary Haemorrhage
on Dec 22, 2009 Female patient from DENMARK , 43 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, pulmonary haemorrhage. Zavedos dosage: Unk. During the same period patient was treated with FLUDARA (Unk) (View Fludara Review and Fludara Label ).

6492239-9 | Acute Leukaemia, Neoplasm Malignant
Patient was taking Zavedos (View Usage). Patient had the following side effects: acute leukaemia, neoplasm malignant on Dec 01, 2009 from FRANCE Additional patient health information: Female patient , 66 years of age, was diagnosed with acute myeloid leukaemia, stem cell transplant and. Zavedos dosage: Unk. During the same period patient was treated with ARACYTINE (Unk) (View Aracytine Review and Aracytine Label ), BUSULFAN (Unk) (View Busulfan Review and Busulfan Label ), ALKERAN (Unk) (View Alkeran Review and Alkeran Label ). Patient was hospitalized.

6460862-3 | Acute Leukaemia, Neoplasm Malignant
Adverse event was reported on Nov 17, 2009 by a Female patient taking Zavedos (View Usage) (Dosage: Unk) was diagnosed with acute myeloid leukaemia, stem cell transplant and. Location: FRANCE , 66 years of age, After Zavedos was administered, patient had the following side effects: acute leukaemia, neoplasm malignant. During the same period patient was treated with ARACYTINE (Unk) (View Aracytine Review and Aracytine Label ), BUSULFAN (Unk) (View Busulfan Review and Busulfan Label ), ALKERAN (Unk) (View Alkeran Review and Alkeran Label ). Patient was hospitalized.

6456861-8 | Bronchopulmonary Aspergillosis, Pulmonary Haemorrhage
on Nov 13, 2009 Female patient from DENMARK , 43 years of age, was diagnosed with acute myeloid leukaemia and was treated with Zavedos (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, pulmonary haemorrhage. Zavedos dosage: Unk. During the same period patient was treated with FLUDARA (Unk) (View Fludara Review and Fludara Label ).

6236281-1 | Bone Marrow Failure
on Jun 09, 2009 Female patient from FRANCE , 56 years of age, was diagnosed with acute promyelocytic leukaemia, psoriatic arthropathy, prophylaxis, gastritis prophylaxis, coronary arterial stent insertion, antiemetic supportive care and was treated with Zavedos (View Usage). Patient had the following side effects: bone marrow failure. Zavedos dosage: 68.4 Mg, Per Day. During the same period patient was treated with METHOTREXATE (15 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ), TAZOCILLINE (4 G, 4x/day) (View Tazocilline Review and Tazocilline Label ), LANZOR (Unk) (View Lanzor Review and Lanzor Label ), TAHOR (Unk) (View Tahor Review and Tahor Label ), VESANOID (Capsule 10 Mg) (View Vesanoid Review and Vesanoid Label ), ASPEGIC 1000 (Unk) (View Aspegic 1000 Review and Aspegic 1000 Label ), KYTRIL (Unk) (View Kytril Review and Kytril Label ), PRIMPERAN (View Primperan Review and Primperan Label ). Patient was hospitalized.

6198129-3 | Febrile Neutropenia
Patient was taking Zavedos (View Usage). After Zavedos was administered, patient had the following side effects: febrile neutropenia on Dec 18, 2008 from AUSTRALIA Additional patient health information: Female patient , 50 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and. Zavedos dosage: 15 Mg, 1x/day. During the same period patient was treated with CYTARABINE (170 Mg, 1x/day) (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (125 Mg, 2x/day) (View Etoposide Review and Etoposide Label ), NEULASTA (6 Mg, 1x/day) (View Neulasta Review and Neulasta Label ), AMBISOME (On Monday, Wednesday And Friday) (View Ambisome Review and Ambisome Label ). Patient was hospitalized.

6185134-6 | Multi-organ Failure, Neutropenic Colitis
Adverse event was reported on May 05, 2009 by a Female patient taking Zavedos (View Usage) (Dosage: 17 Mg) was diagnosed with acute myeloid leukaemia and. Location: AUSTRALIA , 19 years of age, Patient experienced the following unwanted or unexpected effects: multi-organ failure, neutropenic colitis. During the same period patient was treated with CYTARABINE (5.5 G) (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (140 Mg) (View Etoposide Review and Etoposide Label ), PALIFERMIN (4.49 Mg) (View Palifermin Review and Palifermin Label ), PEGFILGRASTIM (6 Mg) (View Pegfilgrastim Review and Pegfilgrastim Label ). Patient was hospitalized.

6108513-1 | Bone Marrow Failure, Cardiac Disorder, Cough, Dyspnoea, Malaise, Mucosal Inflammation, Neutropenic Sepsis, Overdose, White Blood Cell Count Decreased
on Feb 25, 2009 Male patient from UNITED KINGDOM , 69 years of age, weighting 153.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hyperuricaemia, nausea (What is nausea?) and was treated with Zavedos (View Usage). Patient had the following side effects: bone marrow failure, cardiac disorder, cough, dyspnoea, malaise, mucosal inflammation, neutropenic sepsis, overdose, white blood cell count decreased. Zavedos dosage: 70 Mg; Tdd:40 Mg/m2 ,1 In 1 Day. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ). Patient was hospitalized.